Muhammad Ilham Aldika Akbar - Gynecology

Author Information

Muhammad Ilham Aldika Akbar is an esteemed researcher affiliated with the Department of Obstetrics and Gynecology, Faculty of Medicine, Airlangga University, Surabaya, Indonesia. His research primarily focuses on obstetrics and gynecology, with a significant emphasis on preeclampsia and maternal outcomes during pregnancy.

Research Contributions

Muhammad Ilham Aldika Akbar has made substantial contributions to the field of obstetrics and gynecology through his extensive research on preeclampsia, COVID-19 in pregnancy, and maternal health. His notable works include the INOVASIA Study, which investigates the use of Pravastatin to prevent preeclampsia in high-risk patients, and his research on the accuracy of COVID-19 screening methods during pregnancy. He has also explored various biomarkers and their implications in maternal and neonatal health.

Aliases

M.i Aldika Akbar, Muhammad Ilham Aldika Akbar

Publication and Citation Metrics

Metric	Value
Publication Count	11
Citation Count	62
H-Index	5

Publications:

INOVASIA Study: A Multicenter Randomized Clinical Trial of Pravastatin to Prevent Preeclampsia in High Risk Patients.

DOI: 10.1055/a-1798-1925

Year: 2022

INOVASIA Study: A Randomized Open Controlled Trial to Evaluate Pravastatin to Prevent Preeclampsia and its Effects on sFlt1/PLGF Levels.

DOI: 10.1055/a-1673-5603

Year: 2021

Cohort Study: The Accuracy of Screening Methods of COVID-19 in Pregnancy: Practical Approach in Low Resources Health Services

DOI: 10.1101/2021.09.20.21263866

Year: 2021

Cohort study: the accuracy of screening methods of COVID-19 in pregnancy.

DOI: 10.23736/S2724-606X.21.04979-4

Year: 2021

INOVASIA Study: A Randomized Open Controlled Trial to Evaluate Prophylactic Pravastatin in the Prevention of Preeclampsia and its Effects on sFlt1/PLGF Levels in Pregnant Women at High Risk of Developing Preeclampsia

DOI: 10.1101/2021.06.19.21259184

Year: 2021

Successful management of a pregnant woman with COVID-19 and multiple severe complications

DOI: 10.1136/bcr-2021-243594

Year: 2021

Quantitative HBsAg and Qualitative HBeAg Predicts Intrauterine Placental Infection and Umbilical Blood Cord in Pregnant Women

DOI: 10.18502/jfrh.v14i2.4353

Year: 2020

Maternal Perinatal Outcomes Related to Advanced Maternal Age in Preeclampsia Pregnant Women

DOI: 10.18502/jfrh.v13i4.2646

Year: 2019

Serum heme oxygenase 1 (HO-1), soluble FMS like tyrosine kinase (sFlt-1) level, and neonatal outcome in early onset, late onset preeclampsia, and normal pregnancy

DOI: 10.1080/10641955.2018.1494187

Year: 2018

28. The massive problem of preeclampsia in indonesia: In need of a redesigned national health care system

DOI: 10.1016/J.PREGHY.2018.08.051

Year: 2018

How Do Anti-Inflammatory Medications Work?

How to Code Complex Procedures?

Can meditation help in managing PCOS?

Can Mastitis be Prevented?

Can Chronic Stress Impact Fertility?

What is Diet Progression?

When Should Follow-Up Testing Be Conducted?

Why is Maternal Healthcare Important?

Why is LTA Important in Gynecology?

What is the impact of sexually transmitted infections (STIs) in gynecology?

Partnered Content Networks

Relevant Topics